Stay updated on Oral Upadacitinib in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Oral Upadacitinib in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral Upadacitinib in Atopic Dermatitis Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces updates and FAQs about its terminology transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T16:32:40.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T16:27:30.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The revision identifier in the site footer changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T16:20:01.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with standard header/footer, indicating access is blocked and the expected study details are not accessible. This reflects an access restriction rather than an update to study data.
    Difference
    19%
    Check dated 2026-09-19T18:56:19.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5. This indicates a minor update to the page's underlying revision identifier.
    Difference
    0.1%
    Check dated 2026-08-29T20:14:25.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5. This represents a small platform or CMS update and does not alter study information or user-facing content.
    Difference
    0.1%
    Check dated 2026-08-08T18:49:49.000Z thumbnail image

Stay in the know with updates to Oral Upadacitinib in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral Upadacitinib in Atopic Dermatitis Clinical Trial page.